Dimensional Fund Advisors LP Halozyme Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$376 Billion
Q2 2024

A detailed history of Dimensional Fund Advisors LP transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,897,759 shares of HALO stock, worth $108 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,897,759

Previous 1,688,229 12.41%

Holding current value

$108 Million

Previous $68.7 Million 44.69%

% of portfolio

0.03%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$37.81 - $52.4 $7.92 Million - $11 Million	209,530 Added 12.41%	1,897,759 $99.4 Million
Q1 2024 May 10, 2024	BUY	$33.68 - $41.95 $2.53 Million - $3.15 Million	75,116 Added 4.66%	1,688,229 $68.7 Million
Q4 2023 Feb 07, 2024	BUY	$33.32 - $42.1 $4.86 Million - $6.14 Million	145,879 Added 9.94%	1,613,113 $59.6 Million
Q3 2023 Nov 09, 2023	BUY	$36.46 - $44.03 $3.23 Million - $3.9 Million	88,595 Added 6.43%	1,467,234 $56 Million
Q2 2023 Aug 09, 2023	SELL	$30.28 - $38.74 $677,454 - $866,730	-22,373 Reduced 1.6%	1,378,639 $49.7 Million
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $3.32 Million - $5.63 Million	-101,095 Reduced 6.73%	1,401,012 $53.5 Million
Q4 2022 Feb 09, 2023	SELL	$40.06 - $59.44 $1.26 Million - $1.87 Million	-31,393 Reduced 2.05%	1,502,107 $85.5 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $7.11 Million - $9.55 Million	184,486 Added 13.68%	1,533,500 $60.6 Million
Q2 2022 Aug 12, 2022	BUY	$37.35 - $48.3 $6.5 Million - $8.4 Million	174,000 Added 14.81%	1,349,014 $59.4 Million
Q1 2022 May 13, 2022	BUY	$31.97 - $41.06 $1.17 Million - $1.5 Million	36,651 Added 3.22%	1,175,014 $46.9 Million
Q4 2021 Feb 09, 2022	SELL	$31.82 - $40.75 $1.44 Million - $1.84 Million	-45,258 Reduced 3.82%	1,138,363 $45.8 Million
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $17.6 Million - $21.2 Million	456,977 Added 62.89%	1,183,621 $48.1 Million
Q2 2021 Aug 12, 2021	BUY	$38.84 - $51.31 $15.6 Million - $20.5 Million	400,378 Added 122.72%	726,644 $33 Million
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $6.73 Million - $8.76 Million	170,319 Added 109.22%	326,266 $13.6 Million
Q4 2020 Feb 25, 2021	BUY	$25.81 - $43.62 $4.02 Million - $6.8 Million	155,947 New	155,947 $6.66 Million

Others Institutions Holding HALO

# of Institutions

488

Shares Held

122M

Call Options Held

208K

Put Options Held

66.3K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.93B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Halozyme Therapeutics, Inc. Transaction History